The RNA-binding proteins CELF1 and ELAVL1 cooperatively control the alternative splicing of CD44.
暂无分享,去创建一个
S. Deschamps | S. Padilla-Parra | M. Tramier | A. Méreau | L. Paillard | Y. Audic | D. Reboutier | G. David | William Taylor
[1] A. Syahir,et al. CD44: A Multifunctional Mediator of Cancer Progression , 2021, Biomolecules.
[2] M. Hafner,et al. The p53-induced RNA-binding protein ZMAT3 is a splicing regulator that inhibits the splicing of oncogenic CD44 variants in colorectal carcinoma , 2020, Genes & development.
[3] C. Ghigna,et al. Opposite Roles of Tra2β and SRSF9 in the v10 Exon Splicing of CD44 , 2020, Cancers.
[4] D. Dixon,et al. An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells , 2020, Molecular Cancer Therapeutics.
[5] Chonghui Cheng,et al. CD44 splice isoform switching determines breast cancer stem cell state , 2019, Genes & development.
[6] Jian Sun,et al. Human antigen R enhances the epithelial-mesenchymal transition via regulation of ZEB-1 in the human airway epithelium , 2018, Respiratory Research.
[7] Xiaozhao Lu,et al. Adrenaline promotes epithelial-to-mesenchymal transition via HuR-TGFβ regulatory axis in pancreatic cancer cells and the implication in cancer prognosis. , 2017, Biochemical and biophysical research communications.
[8] Y. Yatabe,et al. HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition , 2017, Gut.
[9] C. Shaw,et al. CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT , 2016, Nature Communications.
[10] B. Gschloessl,et al. Identification of CELF1 RNA targets by CLIP-seq in human HeLa cells , 2016, Genomics data.
[11] C. Dong,et al. CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation , 2016, Oncogene.
[12] Robert Brown,et al. TCGASpliceSeq a compendium of alternative mRNA splicing in cancer , 2015, Nucleic Acids Res..
[13] Darren R. Williams,et al. hnRNP L inhibits CD44 V10 exon splicing through interacting with its upstream intron. , 2015, Biochimica et biophysica acta.
[14] O. Elemento,et al. ELAVL1 regulates alternative splicing of eIF4E transporter to promote postnatal angiogenesis , 2014, Proceedings of the National Academy of Sciences.
[15] J. Turánek,et al. Regulation of alternative splicing of CD44 in cancer. , 2014, Cellular signalling.
[16] Michael R. Green,et al. SC35 promotes splicing of the C5-V6-C6 isoform of CD44 pre-mRNA , 2013, Oncology reports.
[17] S. Padilla-Parra,et al. Correction: 827Spatio-Temporal Quantification of FRET in Living Cells by Fast Time-Domain FLIM: A Comparative Study of Non-Fitting Methods , 2013, PLoS ONE.
[18] S. Padilla-Parra,et al. FRET microscopy in the living cell: Different approaches, strengths and weaknesses , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.
[19] A. Masuda,et al. CUGBP1 and MBNL1 preferentially bind to 3′ UTRs and facilitate mRNA decay , 2012, Scientific Reports.
[20] Hiroshi Tanaka,et al. Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell , 2012, Nature Communications.
[21] Jianhua Ruan,et al. Genomic Analyses of the RNA-binding Protein Hu Antigen R (HuR) Identify a Complex Network of Target Genes and Novel Characteristics of Its Binding Sites* , 2011, The Journal of Biological Chemistry.
[22] Uwe Ohler,et al. Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stability. , 2011, Molecular cell.
[23] Chonghui Cheng,et al. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. , 2011, The Journal of clinical investigation.
[24] B. Gschloessl,et al. Chromosome wide analysis of CUGBP1 binding sites identifies the tetraspanin CD9 mRNA as a target for CUGBP1-mediated down-regulation. , 2010, Biochemical and biophysical research communications.
[25] Liujun Tang,et al. PCBP-1 regulates alternative splicing of the CD44 gene and inhibits invasion in human hepatoma cell line HepG2 cells , 2010, Molecular Cancer.
[26] J. Castle,et al. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart , 2008, Proceedings of the National Academy of Sciences.
[27] G. Karypis,et al. Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1. , 2008, Molecular cell.
[28] Julio D Amigo,et al. Gateway compatible vectors for analysis of gene function in the zebrafish , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.
[29] Qing Wang,et al. Stabilization of Snail by HuR in the process of hydrogen peroxide induced cell migration. , 2007, Biochemical and biophysical research communications.
[30] B. Cosson,et al. Oligomerization of EDEN‐BP is required for specific mRNA deadenylation and binding , 2006, Biology of the cell.
[31] A. Shyu,et al. Highly Selective Actions of HuR in Antagonizing AU-Rich Element-Mediated mRNA Destabilization , 2002, Molecular and Cellular Biology.
[32] T. Cooper,et al. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. , 1998, Science.
[33] L. Paillard,et al. A strategy to analyze the phenotypic consequences of inhibiting the association of an RNA-binding protein with a specific RNA. , 2010, RNA.